NEW YORK, NY / ACCESS Newswire / August 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Snap Inc. ("Snap Inc.") (NYSE:SNAP) concerning possible violations of federal securities laws. Investors.com reported on August 6, 2025, that "Snap . . . stock tumbled Wednesday after the Snapchat parent company posted […]
NEW YORK, NY / ACCESS Newswire / August 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Thomson Reuters Corporation ("Thomson Reuters Corporation") (NASDAQ:TRI) concerning possible violations of federal securities laws. On August 6, 2025, Thomson Reuters published a press release reporting the Company’s second quarter 2025 results. During
NEW YORK, NY / ACCESS Newswire / August 15, 2025 / If you suffered a loss on your Sarepta Therapeutics, Inc. (NASDAQ:SRPT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sarepta-lawsuit-submission-form?prid=161604&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 15, 2025 / If you suffered a loss on your Neogen Corporation (NASDAQ:NEOG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neogen-corporation-lawsuit-submission-form?prid=161603&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
Results Highlights: – Revenue reached US$83.6 million, a year-on-year increase of 5.9%.– Sales volume reached 919,000 units, of which 779,000 units were proprietary products, representing a year-on-year increase of 8.6%.– Profit attributable to owners of the company increased by 5.1% year-on-year to US$19.8 million.– Core operating profit amounted to US$15.1 million, an increase of 11.4%
NEW YORK, NY / ACCESS Newswire / August 15, 2025 / If you suffered a loss on your Fiserv, Inc. (NYSE:FI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fiserv-inc-lawsuit-submission-form?prid=161601&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 15, 2025 / If you suffered a loss on your Alto Neuroscience, Inc. (NYSE:ANRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/alto-neuroscience-inc-lawsuit-submission-form?prid=161602&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of C3.ai, Inc. ("C3.ai, Inc.") (NYSE:AI) concerning possible violations of federal securities laws. On August 8, 2025, after the market closed, C3 unveiled disappointing preliminary financial results for the first quarter of fiscal
NEW YORK, NY / ACCESS Newswire / August 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Evolent Health, Inc. ("Evolent Health, Inc.") (NYSE:EVH) concerning possible violations of federal securities laws. On August 8, 2025, Evolent issued a press release announcing second quarter revenue results that were below analysts’
NEW YORK, NY / ACCESS Newswire / August 15, 2025 / If you suffered a loss on your Flywire Corporation (NASDAQ:FLYW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/flywire-corporation-lawsuit-submission-form?prid=161608&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call